FDA Warning: Surgical mesh may not be best route

The Federal Drug Administration (FDA) recently issued a warning regarding serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse.  Patients who've undergone pelvic organ prolapse (POP) or stress urinary incontinence (SUI) have suffered serious complications from transvaginal mesh.  According to the FDA's warning: "Serious complications associated with surgical mesh for transvaginal repair of POP are not rare."  The FDA also explained that "it is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in all patients with POP and it may expose patients to a greater risk."  To learn more about the warning from the FDA or symptoms associated with transvaginal mesh, read the full article at http://www.thesafetyreport.com/  Article ID: 2414